New York, NY – February 5, 2025 – Sichenzia Ross Ference Carmel LLP announced that it represented 60 Degrees Pharmaceuticals, Inc. (Nasdaq: SXTP; SXTPW), a pharmaceutical company focused on developing new medicines for infectious diseases, in its $1.075 million registered direct offering and concurrent private placement.
H.C. Wainwright & Co. acted as the sole placement agent for the offering.
The SRFC team was led by partner Ross Carmel, counsel Jeff Hua and associate Tong Wu.
